Amgen Research Development from 2010 to 2026

AMG Stock  EUR 329.30  11.55  3.63%   
Amgen Research Development yearly trend continues to be very stable with very little volatility. Research Development is likely to drop to about 5.3 B. During the period from 2010 to 2026, Amgen Research Development quarterly data regression pattern had sample variance of 1164601.7 T and median of  3,840,000,000. View All Fundamentals
 
Research Development  
First Reported
2019-03-31
Previous Quarter
1.9 B
Current Value
2.1 B
Quarterly Volatility
322 M
 
Covid
 
Interest Hikes
Check Amgen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amgen's main balance sheet or income statement drivers, such as Tax Provision of 1.4 B, Interest Income of 218.9 M or Interest Expense of 1.7 B, as well as many indicators such as . Amgen financial statements analysis is a perfect complement when working with Amgen Valuation or Volatility modules.
  
This module can also supplement various Amgen Technical models . Check out the analysis of Amgen Correlation against competitors.
Evaluating Amgen's Research Development across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Amgen Inc's fundamental strength.

Latest Amgen's Research Development Growth Pattern

Below is the plot of the Research Development of Amgen Inc over the last few years. It is Amgen's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amgen's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Amgen Research Development Regression Statistics

Arithmetic Mean4,505,082,353
Geometric Mean4,402,299,929
Coefficient Of Variation23.95
Mean Deviation838,233,910
Median3,840,000,000
Standard Deviation1,079,167,151
Sample Variance1164601.7T
Range3.7B
R-Value0.74
Mean Square Error565931.7T
R-Squared0.54
Significance0.0007
Slope157,684,314
Total Sum of Squares18633627.8T

Amgen Research Development History

20265.3 B
20257.3 B
2024B
20234.8 B
20224.4 B
20216.3 B
20204.2 B

About Amgen Financial Statements

Amgen investors utilize fundamental indicators, such as Research Development, to predict how Amgen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Research Development7.3 B5.3 B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Check out the analysis of Amgen Correlation against competitors.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Understanding that Amgen's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Amgen represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Amgen's market price signifies the transaction level at which participants voluntarily complete trades.